agilon health, inc. (NYSE: AGL) stock experienced a significant drop of 5.07% in the pre-market trading session on Friday, following the release of its full-year results and analysts' revised forecasts.
The healthcare company reported revenue in line with expectations at $6.1 billion for the fiscal year. However, it reported a larger-than-expected statutory loss of $0.63 per share, which raised concerns among investors.
Analyst projections for the upcoming year have been revised, with revenue estimates lowered to $6.10 billion, approximately in line with the previous year. Additionally, analysts expect agilon health's revenue growth to slow substantially, projecting an annualized growth rate of 0.6% compared to the historical five-year growth rate of 38%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.